Team:Westminster

From 2012.igem.org

(Difference between revisions)
 
(213 intermediate revisions not shown)
Line 1: Line 1:
 +
<html>
-
<!--- The Mission, Experiments --->
+
<head>
-
{| style="color:#1b2c8a;background-color:#aee0bd;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center"
+
<meta http-equiv="content-type" content="text/php; charset=utf-8" />
-
!align="center"|[[Team:Westminster|Home]]
+
 
-
!align="center"|[[Team:Westminster/Team|Team]]
+
<style type="text/css">
-
!align="center"|[https://igem.org/Team.cgi?year=2012&team_name=Westminster Official Team Profile]
+
@import url 'http://yui.yahooapis.com/2.9.0/build/reset/reset-min.css';
-
!align="center"|[[Team:Westminster/Project|Project]]
+
ul {
-
!align="center"|[[Team:Westminster/Parts|Parts Submitted to the Registry]]
+
list-style: none;
-
!align="center"|[[Team:Westminster/Modeling|Modeling]]
+
}
-
!align="center"|[[Team:Westminster/Notebook|Notebook]]
+
body {
-
!align="center"|[[Team:Westminster/Safety|Safety]]
+
font-family:  "HelveticaNeue-Light", "Helvetica Neue Light", "Helvetica Neue", Helvetica, Arial, "Lucida Grande", sans-serif;
-
!align="center"|[[Team:Westminster/Attributions|Attributions]]
+
font-weight: 300;
-
|}
+
/* background: url("http://www.westminsterigem.com/files/theme/body-bg.png") repeat #ffffff;*/
 +
background-color:#FFF;
 +
color: #666666;
 +
 +
}
 +
h1 {
 +
color: #ff0000;
 +
font-size: 18pt;
 +
margin-bottom: 0.5em;
 +
}
 +
p {
 +
 
 +
}
 +
a {
 +
 +
}
 +
#p-logo {
 +
background: #444444;
 +
}
 +
div#top-section,
 +
div#content {
 +
box-shadow: 0px 0px 17px -4px #666666;
 +
padding:0px;
 +
margin-top:0px;
 +
 
 +
}
 +
div#wrapper {
 +
position: relative;
 +
width: 100%;
 +
font-size: 12pt;
 +
margin: 0 auto;
 +
background: #ffffff;
 +
background-attachment: url('https://static.igem.org/mediawiki/2012/2/2e/Bg-tumours.png');
 +
background-repeat: no-repeat;
 +
 +
padding:0px;
 +
margin-top:0px;
 +
top:0px;
 +
 +
}
 +
div#header {
 +
height: 120px;
 +
width: 100%;
 +
background-color:#000;
 +
background: url('https://static.igem.org/mediawiki/2012/2/2e/Bg-tumours.png');
 +
background-repeat: no-repeat;
 +
z-index:10;
 +
position:relative;
 +
top:0px;
 +
left:0px;
 +
}
 +
div#header div#logo {
 +
position: relative;
 +
width: 260px;
 +
right:10px;
 +
top:-9px;
 +
float:right;
 +
 
 +
margin-bottom: 0px;
 +
/*
 +
height: 0px;
 +
margin: 0 auto;*/
 +
}
 +
div#header div#logo a {
 +
float:left;
 +
display:block;
 +
margin-left:10px;
 +
 
 +
}
 +
 
 +
 +
div#navigation {
 +
width: 850px;
 +
height: 27px;
 +
background:rgba(0,0,0,.5);
 +
float:left;
 +
position:relative;
 +
top:54px;
 +
}
 +
ul#navigation-list {
 +
height: 27px;
 +
line-height: 27px;
 +
overflow: auto;
 +
}
 +
ul#navigation-list > li {
 +
float: left;
 +
margin-top:-5px;
 +
}
 +
ul#navigation-list > li > ul {
 +
position: absolute;
 +
display: none;
 +
background: #000000;
 +
z-index: 100000;
 +
}
 +
ul#navigation-list > li > ul.submenu {
 +
margin: 0;
 +
}
 +
ul#navigation-list > li > ul.submenu li {
 +
padding: 2px 0px;
 +
}
 +
ul#navigation-list a.navlink {
 +
color: #ffffff;
 +
font-weight: normal;
 +
display: block;
 +
padding: 0px 10px;
 +
text-decoration: none;
 +
}
 +
ul#navigation-list a.navlink.active,
 +
ul#navigation-list a.navlink:hover {
 +
color: #ff0000;
 +
}
 +
div#home-main-image {
 +
text-align: center;
 +
background-color: #410000;
 +
height:475px;
 +
border-bottom:1px #000 solid;
 +
}
 +
div#the-content {
 +
position:relative;
 +
top:-19px;
 +
 +
}
 +
div#home-main-image img {
 +
/*width: 885px;
 +
height: 300px;
 +
margin-bottom: 20px;
 +
border-radius: 20px;
 +
*/
 +
}
 +
div.text-box {
 +
background: #444444;
 +
color: #ffffff;
 +
padding: 15px 20px;
 +
border-radius: 10px;
 +
 +
}
 +
div#footer-box {
 +
border-radius: 0 0 5px 5px;
 +
}
 +
#bodyContent {
 +
}
 +
#three-column
 +
{
 +
margin:0 auto;
 +
width:850px;
 +
margin-top:50px;
 +
 +
}
 +
 +
.col
 +
{
 +
text-align:justify; float:left; margin:5px;
 +
}
 +
.col h1
 +
{
 +
font-size:14px;
 +
color:#000;
 +
 +
}
 +
/* hide native rubbish*/
 +
#top-section {display:none; position:absolute; left:0px; top:-200px;}
 +
#top-section a { color:#FFF; }
 +
.firstHeading {display:none; position:absolute; left:0px; top:-200px;}
 +
.annoying-gap {
 +
padding:0px;
 +
margin:0px;
 +
line-height:0;
 +
}
 +
 +
#contentSub, #siteSub {display:none;}
 +
 +
#control-btn
 +
{
 +
 +
width: 20px;
 +
height: 20px;
 +
position:absolute;
 +
top:0px;
 +
left:5px;
 +
 +
line-height: 0px;
 +
 +
 +
}
 +
.btn-cog {
 +
background: url('https://static.igem.org/mediawiki/2012/d/d4/Control-panel-sml.png') #000 no-repeat  2px 2px;
 +
}
 +
.btn-close {
 +
background: url('https://static.igem.org/mediawiki/2012/d/d0/Close-btn.png')  #000 no-repeat  2px 2px;
 +
}
 +
.right-menu li a, .left-menu li a {background: none}
 +
</style>
 +
 
 +
<script type="text/javascript" src="http://code.jquery.com/jquery-1.8.2.min.js"></script>
 +
<script type="text/javascript">
 +
$('document').ready(function() {
 +
 +
// menu
 +
$('li.submenu-holder').hover(function() {
 +
$(this).children('ul.submenu').stop(true).fadeIn('fast');
 +
}, function() {
 +
$(this).children('ul.submenu').stop(true).fadeOut('fast');
 +
});
 +
 
 +
              // hide standard team basics
 +
              $('#top-section').hide();
 +
  $('#bodyContent p:first').addClass("annoying-gap");
 +
 
 +
 +
$('#control-btn').click( function(){
 +
 +
if ($('#control-btn').hasClass("btn-cog"))
 +
{
 +
showTopMenu();
 +
$('#control-btn').animate({left: "-20px"});
 +
$('#control-btn').addClass("btn-close");
 +
$('#control-btn').removeClass("btn-cog");
 +
} else
 +
{
 +
hideTopMenu();
 +
$('#control-btn').animate({left: "0px"});
 +
$('#control-btn').addClass("btn-cog");
 +
$('#control-btn').removeClass("btn-close");
 +
}
 +
});
 +
 +
});
 +
 +
 +
 +
 +
var $bar;
 +
function hideTopMenu()
 +
{
 +
$bar.slideUp('fast');
 +
 +
}
 +
function showTopMenu()
 +
{
 +
if ($bar==null)
 +
{
 +
$bar = $("#top-section").clone();
 +
$($bar.find("#search-controls")).remove();
 +
$($bar.find("#p-logo")).remove();
 +
$("#wrapper").prepend($bar);
 +
$bar.css("position", "absolute");
 +
$bar.css("top", "0px");
 +
$bar.css("left", "0px");
 +
$bar.css("background", "none");
 +
$bar.css("background", "rgba(0,0,0,.5)");
 +
$bar.css("height", "20px");
 +
$bar.css("border", "none");
 +
$bar.css("z-index", "100");
 +
$bar.css("color", "#000");
 +
 +
 +
}
 +
$bar.slideDown('fast');
 +
 +
$('#control-btn').mouseover( function(){
 +
 +
});
 +
}
 +
</script>
 +
</head>
 +
 
 +
<body>
 +
<div id="wrapper">
 +
 
 +
<div id="header">
 +
  <div id="control-btn" class="btn-cog"></div>
 +
 
 +
<div id="navigation">
 +
<ul id="navigation-list">
 +
<li><a href="https://2012.igem.org/Team:Westminster" class="navlink active">Home</a></li>
 +
<li><a href="https://2012.igem.org/Team:Westminster/Team" class="navlink">Team</a></li>
 +
<li class="submenu-holder">
 +
<a href="https://2012.igem.org/Team:Westminster/Overview"class="navlink">Project</a>
 +
 
 +
<ul class="submenu">
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Overview"class="navlink">Overview</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Problem"class="navlink">The Problem</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Experiments"class="navlink">Experiments</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Protocols"class="navlink">Protocols</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Results"class="navlink">Results</a></li>
 +
 
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Safety"class="navlink">Safety</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Journal"class="navlink">Journal</a></li>
 +
                           
 +
                 
 +
</ul>
 +
</li>
 +
<li><a href="https://2012.igem.org/Team:Westminster/Parts"class="navlink">Parts</a></li>
 +
<li><a href="https://2012.igem.org/Team:Westminster/Modeling"class="navlink">Modeling</a></li>
 +
<li><a href="https://2012.igem.org/Team:Westminster/Outreach"class="navlink">Outreach</a></li>
 +
                    <li><a href="https://2012.igem.org/Team:Westminster/Judging"class="navlink">Judging Criteria</a></li>
 +
 
 +
 +
<li><a href="https://2012.igem.org/Team:Westminster/Attributions"class="navlink">Attributions</a></li>
 +
</ul><!-- #navigation-list -->
 +
</div><!-- #navigation -->
 +
            <div id="logo">
 +
                    <a href="http://www.igem.org" title="iGEM homepage"><img src="https://static.igem.org/mediawiki/igem.org/d/dc/Igem-small-white.png" alt="iGEM logo" width="55" height="44" /></a>
 +
<a href="https://2012.igem.org/Team:Westminster">
 +
<img src="https://static.igem.org/mediawiki/2012/a/ae/Logo-white.png" alt="iSTEM - intelligent synthetic tumour eliminating machine" width="172" height="66" title="iSTEM - intelligent synthetic tumour eliminating machine" />
 +
</a>
 +
</div><!-- #logo -->
 +
</div><!-- #header -->
 +
 
 +
<div id="the-content">
 +
<div id="home-main-image">
 +
<!--img src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" alt="Welcome" title="Welcome to our home!" /--->
 +
      <div style="float:left;padding-left:30px;padding-top:50px; width:380px">
 +
            <h1 style="text-align:left;border:none; color:#fff; position:relative;bottom:0px; left:0px; margin:0px; padding:0px 0px 20px 0px;">Fighting cancer from the inside out</h1>
 +
<div style="color:white; text-align:justify;">Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.<br/><br/>
 +
The Westminster iGEM 2012 team aims to combat cancer recurrence by using one key feature of CSCs – increased Aldehyde Dehydrogenase (ALDH) activity. We have used the promoters of 4 different ALDH isoforms present in aggressive forms of cancer to design 3 constucts that will allow us to identify, isolate and eliminate CSC, offering a novel tool for the study of these cells and a potential new anti-cancer therapy for the future.</div>
-
<!-- *** What falls between these lines is the Alert Box!  You can remove it from your pages once you have read and understood the alert *** -->
 
-
<html>
 
-
<div id="box" style="width: 700px; margin-left: 137px; padding: 5px; border: 3px solid #000; background-color: #fe2b33;">
 
-
<div id="template" style="text-align: center; font-weight: bold; font-size: large; color: #f6f6f6; padding: 5px;">
 
-
This is a template page. READ THESE INSTRUCTIONS.
 
</div>
</div>
-
<div id="instructions" style="text-align: center; font-weight: normal; font-size: small; color: #f6f6f6; padding: 5px;">
+
<div style="float:left; width:500px; padding-left:50px; padding-top:150px; text-align:center">
-
You are provided with this team page template with which to start the iGEM season.  You may choose to personalize it to fit your team but keep the same "look." Or you may choose to take your team wiki to a different level and design your own wiki.  You can find some examples <a href="https://2009.igem.org/Help:Template/Examples">HERE</a>.
+
<img src="https://static.igem.org/mediawiki/2012/8/8a/Tumor.png" alt="Tumor" width="218" height="179" />
</div>
</div>
-
<div id="warning" style="text-align: center; font-weight: bold; font-size: small; color: #f6f6f6; padding: 5px;">
 
-
You <strong>MUST</strong> have all of the pages listed in the menu below with the names specified. PLEASE keep all of your pages within your teams namespace. 
 
-
</div>
 
-
</div>
 
-
</html>
 
-
<!-- *** End of the alert box *** -->
+
</div><!-- #home-main-image -->
 +
 +
 +
           
 +
  <div id="three-column">
 +
 
 +
  <div class="col">
 +
    <img src="https://static.igem.org/mediawiki/igem.org/d/d7/IntegratedDNALogo.jpg" width="146" height="61"/>
 +
    </div>
 +
    <div class="col">
 +
    <img src="https://static.igem.org/mediawiki/igem.org/b/b9/GeneiousLogo.jpg" width="136" height="54"/>
 +
    </div>
 +
    <div class="col">
 +
    <img src="https://static.igem.org/mediawiki/igem.org/a/af/MathWorksLogo.jpg" width="202" height="40"/>
 +
    </div>
 +
    <div class="col">
 +
    <img src="https://static.igem.org/mediawiki/igem.org/8/8e/AutodeskLogo.jpg" width="161" height="41"/>
 +
    </div>
 +
    <div class="col">
 +
    <img src="https://static.igem.org/mediawiki/igem.org/c/c7/UniversityWestminsterLogo.jpg"/>
 +
    </div>
 +
   
 +
  </div>
 +
</div><!-- #the-content -->
 +
</div><!-- #wrapper -->
-
{|align="justify"
 
-
|You can write a background of your team here.  Give us a background of your team, the members, etc.  Or tell us more about something of your choosing.
+
</body>
-
|[[Image:Westminster_logo.png|200px|right|frame]]
+
 
-
|-
+
</html>
-
|
+
 
-
''Tell us more about your project.  Give us background.  Use this as the abstract of your project.  Be descriptive but concise (1-2 paragraphs)''
+
[[iGEM 2013]]
-
|[[Image:Westminster_team.png|right|frame|Your team picture]]
+
-
|-
+
-
|
+
-
|align="center"|[[Team:Westminster | Team Westminster]]
+
-
|}
+

Latest revision as of 18:58, 9 August 2013

Fighting cancer from the inside out

Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.

The Westminster iGEM 2012 team aims to combat cancer recurrence by using one key feature of CSCs – increased Aldehyde Dehydrogenase (ALDH) activity. We have used the promoters of 4 different ALDH isoforms present in aggressive forms of cancer to design 3 constucts that will allow us to identify, isolate and eliminate CSC, offering a novel tool for the study of these cells and a potential new anti-cancer therapy for the future.
Tumor

iGEM 2013